List of insiders holdings for Crinetics Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
2024-02-14 18:36:08 | 1,667,360 0 |
1,667,360 | Form 13G |
| 2 | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
2024-03-01 20:05:26 | 1,488,703 0 |
1,488,703 | Form 13D |
| 3 | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. Former 10% holder |
2021-02-16 06:31:14 | 1,362,286 0 |
1,362,286 | Form 13G |
| 4 | Struthers Richard Scott President & CEO |
2025-04-04 16:30:05 | 410,417 891,805 |
1,302,222 | Form 4 |
| 5 | Versant Venture Capital V L.P. Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP Versant Ventures V LLC Versant Ventures V (Canada) L.P. 10% Owner |
2022-02-10 20:21:59 | 382,961 0 |
382,961 | Form 13G |
| 6 | Madan Ajay Chief Development Officer |
2022-03-02 21:00:35 | 242,395 0 |
242,395 | Form 4 |
| 7 | Krasner Alan Seth Chief Medical Officer |
2023-10-19 17:01:13 | 196,683 0 |
196,683 | Form 4 |
| 8 | Hassard James Chief Commercial Officer |
2024-07-09 18:04:39 | 159,259 0 |
159,259 | Form 4 |
| 9 | Schilke Tobin Chief Financial Officer |
2025-03-11 16:30:06 | 132,000 0 |
132,000 | Form 4 |
| 10 | WIERENGA WENDALL Director |
2024-06-11 16:18:42 | 121,746 0 |
121,746 | Form 4 |
| 11 | Wilson Marc CFO |
2025-01-29 16:30:04 | 112,038 0 |
112,038 | Form 5 |
| 12 | Betz Stephen F. Chief Scientific Officer |
2025-03-21 18:32:29 | 108,588 0 |
108,588 | Form 4 |
| 13 | Kalofonos Isabel Chief Commercial Officer |
2025-01-13 16:30:06 | 100,000 0 |
100,000 | Form 4 |
| 14 | Knight Jeff E. Chief Operating Officer |
2025-03-21 18:33:31 | 87,491 0 |
87,491 | Form 4 |
| 15 | Pizzuti Dana Chief Med and Dev Officer |
2025-03-21 18:34:04 | 72,233 0 |
72,233 | Form 4 |
| 16 | Freeman Mason Director |
2018-07-17 20:42:55 | 54,711 0 |
54,711 | Form 3 |
| 17 | Fust Matthew K Director |
2024-06-11 16:19:49 | 34,436 0 |
34,436 | Form 4 |
| 18 | Vivaldi Coelho Rogerio Director |
2024-06-11 16:21:26 | 26,900 0 |
26,900 | Form 4 |
| 19 | Nichols Weston Director |
2024-06-11 16:20:13 | 21,900 0 |
21,900 | Form 4 |
| 20 | Deardorf Caren Director |
2024-06-11 16:21:55 | 21,900 0 |
21,900 | Form 4 |
| 21 | Okey Stephanie Director |
2024-06-11 16:20:49 | 21,900 0 |
21,900 | Form 4 |
| 22 | Bedrosian Camille L Director |
2024-06-11 16:19:10 | 21,900 0 |
21,900 | Form 4 |
| 23 | Kaldor Stephen W Director |
2020-06-22 16:22:47 | 12,500 0 |
12,500 | Form 4 |
| 24 | Nielsen Jack Director |
2019-06-25 16:10:05 | 12,500 0 |
12,500 | Form 4 |
| 25 | Vivo Capital VIII LLC Vivo Capital LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner |
2022-02-11 17:22:24 | 0 0 |
0 | Form 13G |
| 26 | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
2022-02-11 17:22:24 | 0 0 |
0 | Form 13G |
| 27 | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner |
2022-02-11 17:22:24 | 0 0 |
0 | Form 13G |